Kaisa Health Group Holdings Full Year 2023 Earnings: EPS: HK$0.002 (vs HK$0.024 loss in FY 2022)

Kaisa Health Group Holdings (HKG:876) Full Year 2023 Results

Key Financial Results

• Revenue: HK$185.9m (down 2.9% from FY 2022).
• Net income: HK$7.47m (up from HK$123.3m loss in FY 2022).
• Profit margin: 4.0% (up from net loss in FY 2022).
• EPS: HK$0.002 (up from HK$0.024 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kaisa Health Group Holdings shares are down 12% from a week ago.

Risk Analysis

You should learn about the 3 warning signs we've spotted with Kaisa Health Group Holdings (including 1 which doesn't sit too well with us).

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.